Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "f hoffmann la roche ltd"

Roche announces resignation of board member

F. Hoffmann-La Roche Ltd has announced the resignation of Arthur Levinson from the board of directors. Arthur D. Levinson made this decision so as to avoid any conflict of interest given his role as CEO at Calico. "I would like to thank Art for ... Individual.com, 1 week ago

5 images for f hoffmann la roche ltd

On Office, 3 weeks ago
ABC News 4 Charleston, 6 days ago
Sys-Con Media, 1 week ago
Livemint.com, 1 month ago
Scottrade, 2 months ago

Roche receives European Commission approval for ovarian cancer therapy

F. Hoffmann-La Roche Ltd has received approval from the European Commission, or EU, for the use of Avastin in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin chemotherapy as a treatment for women with recurrent ovarian ...
 Individual.com4 weeks ago

Chugai Pharma amends business arrangements with Roche

Chugai Pharmaceutical has amended the business arrangements with F. Hoffmann-La Roche Ltd. (Roche) regarding the terms and conditions for out-licencing Chugai products based on the strategic alliance between Chugai and Roche. Pursuant to the Basic ...
 PharmaBiz3 weeks ago Amendment of Business Arrangements Regarding the Conditions for Out-Licensing Chugai Products Based on the Strategic Alliance between Chugai and Roche  Noodls3 weeks ago CHUGAI PHARMACEUTICAL : Launch of the Anti-Cancer Agent / ALK Inhibitor Alecensa┬«  4 Traders2 weeks ago CHUGAI PHARMACEUTICAL : Amendment of Business Arrangements Regarding the Conditions for Out-Licensing Chugai Products Based on the Strategic Alliance between Chugai and Roche  4 Traders3 weeks ago

Chugai Pharma launches ant-cancer agent Alecensa capsules

Chugai Pharmaceutical, a subsidiary drug manufacturer operating in Japan controlled by HoffmannLa Roche, has launched the ALK inhibitor Alecensa capsule 20mg and 40mg (alectinib hydrochloride) for the indication of ALK fusion gene positive ...
 PharmaBiz2 weeks ago Chugai Pharmaceutical launches non-small cell lung cancer drug  Individual.com1 week ago

Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis

DUBLIN , Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Breast Cancer Market 2014-2018" report to their offering. Breast cancer is characterized by the uncontrolled growth of cancerous cells in the ...
 Market Pulse Navigator3 days ago Global Transcriptomics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and Thermo Fisher Scientific  Sys-Con India21 hours ago Research and Markets: Global Hodgkins Lymphoma Therapeutics Market 2014-2018: Bristol Myers Squibb, F. Hoffmann-La Roche, Merck & Co & Pfizer Dominate the Industry  Market Pulse Navigator4 weeks ago Global Hodgkins Lymphoma Therapeutics Market 2014-2018: Bristol Myers Squibb, F. Hoffmann-La Roche, Merck & Co & Pfizer Dominate the Industry  Individual.com4 weeks ago
[x]  

POCT Market in China 2014-2018

FEATURED COMPANIES Abbott Laboratories Bayer HealthCare Bioptik Technology F. Hoffmann-La Roche Fudakang Ind'l LifeScan MORE About POCT POCT, also called near-patient ...
 Research and Markets2 days ago Genomics Market in the US 2014-2018  Research and Markets2 days ago

New Clinical Trials and Studies Study Results Reported from F. Hoffmann-La Roche (The use of phase 2 interim analysis to expedite drug development...

New Clinical Trials and Studies Study Results Reported from F. Hoffmann-La Roche (The use of phase 2 interim analysis to expedite drug development decisions) By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators discuss ...
 4 Traders2 weeks ago Fatty Liver Disease Global Clinical Trials Review, H2, 2014  Tamar Securities2 weeks ago Atherosclerosis Global Clinical Trials Review, H2, 2014  Review Seeker2 weeks ago New Market Research Report: Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014  MoneyShow.com3 weeks ago
[x]  

Researchers at F. Hoffmann-La Roche Report New Data on Medicinal Chemistry (Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994,...

Researchers at F. Hoffmann-La Roche Report New Data on Medicinal Chemistry (Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy) By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators ...
 4 Traders3 weeks ago

Patent Issued for Conjugate and Its Use as a Standard in an Immunoassay

By a News Reporter-Staff News Editor at Biotech Week -- Hoffmann-La Roche Inc. ( Nutley, NJ ) has been issued patent number 8809005, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also Pharmaceutical ...
 4 Traders3 weeks ago Patent Issued for Azetidine Compounds, Compositions and Methods of Use  4 Traders3 weeks ago

Osteoporosis Drugs Market - Global Industry Analysis and Forecast to 2020 by Persistence Market Research

Persistence Market Research Released New Market Report on Osteoporosis Drugs Market - Global Industry Analysis and Forecast to 2020 in the category "Pharmaceuticals" New York, NY -- (ReleaseWire) -- 09/19/2014 -- Orthopedics market is witnessing ...
 Digital Journal1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less